Jong M. Rho - Publications

Barrow Neurological Institute, Phoenix, AZ, United States 
epilepsy, neuropharmacology, ketogenic diet

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Rho JM, Boison D. The metabolic basis of epilepsy. Nature Reviews. Neurology. PMID 35361967 DOI: 10.1038/s41582-022-00651-8  0.308
2021 Choudhary A, Mu C, Barrett KT, Charkhand B, Williams-Dyjur C, Marks WN, Shearer J, Rho JM, Scantlebury MH. The link between brain acidosis, breathing and seizures: a novel mechanism of action for the ketogenic diet in a model of infantile spasms. Brain Communications. 3: fcab189. PMID 34734183 DOI: 10.1093/braincomms/fcab189  0.32
2021 Johannesen KM, Liu Y, Koko M, Gjerulfsen CE, Sonnenberg L, Schubert J, Fenger CD, Eltokhi A, Rannap M, Koch NA, Lauxmann S, Krüger J, Kegele J, Canafoglia L, Franceschetti S, ... ... Rho JM, et al. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. Brain : a Journal of Neurology. PMID 34431999 DOI: 10.1093/brain/awab321  0.325
2021 Cervenka M, Pascual JM, Rho J, Thiele E, Yellen G, Whittemore V, Hartman AL. Metabolism-based therapies for epilepsy: new directions for future cures. Annals of Clinical and Translational Neurology. PMID 34247456 DOI: 10.1002/acn3.51423  0.567
2021 Simeone KA, Wilke JC, Matthews SA, Simeone TA, Rho JM. Ketogenic diet-mediated seizure reduction preserves CA1 cell numbers in epileptic Kcna1-null mice: An unbiased stereological assessment. Epilepsia. PMID 34231878 DOI: 10.1111/epi.16983  0.73
2020 Gavrilovici C, Rho JM. Metabolic Epilepsies Amenable to Ketogenic Therapies: Indications, Contra-indications and Underlying Mechanisms. Journal of Inherited Metabolic Disease. PMID 32654164 DOI: 10.1002/Jimd.12283  0.386
2020 Kiroski I, Jiang Y, Gavrilovici C, Gao F, Lee S, Scantlebury MH, Vandal M, Park SK, Tsai LH, Teskey GC, Rho JM, Nguyen MD. Reelin Improves Cognition and Extends the Lifespan of Mutant Ndel1 Mice with Postnatal CA1 Hippocampus Deterioration. Cerebral Cortex (New York, N.Y. : 1991). PMID 32328622 DOI: 10.1093/Cercor/Bhaa088  0.314
2020 Ibhazehiebo K, Rho JM, Kurrasch DM. Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies. Neuropharmacology. 167: 107988. PMID 32070912 DOI: 10.1016/j.neuropharm.2020.107988  0.387
2019 Poff AM, Rho JM, D'Agostino DP. Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives. Frontiers in Neuroscience. 13: 1041. PMID 31680801 DOI: 10.3389/fnins.2019.01041  0.48
2019 Appendino JP, Boelman C, Brna PM, Burneo JG, Claassen CS, Connolly MB, De Guzman M, Federico P, Floyd D, Huntsman R, Javidan M, Jetté N, Jurasek LL, Keezer M, Lau JC, ... ... Rho JM, et al. POSITION STATEMENT ON THE USE OF MEDICAL CANNABIS FOR THE TREATMENT OF EPILEPSY IN CANADA. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-39. PMID 31466531 DOI: 10.1017/Cjn.2019.282  0.314
2019 Boison D, Rho JM. Epigenetics and epilepsy prevention: the therapeutic potential of adenosine and metabolic therapies. Neuropharmacology. 107741. PMID 31419398 DOI: 10.1016/j.neuropharm.2019.107741  0.384
2019 Rho JM, Shao LR, Stafstrom CE. 2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control. Frontiers in Cellular Neuroscience. 13: 172. PMID 31114484 DOI: 10.3389/fncel.2019.00172  0.434
2019 Jobst BC, Ben-Menachem E, Chapman KE, Fu A, Goldman A, Hirsch LJ, Jehi LE, Kossoff EH, Plueger M, Rho JM, Schevon CA, Shinnar S, Sperling MR, Simeone TA, Wagner JL, et al. Highlights From the Annual Meeting of the American Epilepsy Society 2018. Epilepsy Currents. 1535759719844486. PMID 31050308 DOI: 10.1177/1535759719844486  0.729
2018 Shao LR, Rho JM, Stafstrom CE. Glycolytic inhibition: A novel approach toward controlling neuronal excitability and seizures. Epilepsia Open. 3: 191-197. PMID 30564778 DOI: 10.1002/epi4.12251  0.349
2018 Rho JM, White HS. Brief history of anti-seizure drug development. Epilepsia Open. 3: 114-119. PMID 30564769 DOI: 10.1002/epi4.12268  0.486
2018 Wallace E, Wright S, Schoenike B, Roopra A, Rho JM, Maganti RK. Altered circadian rhythms and oscillation of clock genes and sirtuin 1 in a model of sudden unexpected death in epilepsy. Epilepsia. PMID 30009381 DOI: 10.1111/Epi.14513  0.357
2018 Masino SA, Rho JM. Metabolism and epilepsy: Ketogenic diets as a homeostatic link. Brain Research. PMID 29883626 DOI: 10.1016/j.brainres.2018.05.049  0.428
2018 Lewis ML, Kesler M, Candy SA, Rho JM, Pittman QJ. Comorbid epilepsy in autism spectrum disorder: Implications of postnatal inflammation for brain excitability. Epilepsia. PMID 29858515 DOI: 10.1111/Epi.14440  0.312
2018 Ibhazehiebo K, Gavrilovici C, de la Hoz CL, Ma SC, Rehak R, Kaushik G, Meza Santoscoy PL, Scott L, Nath N, Kim DY, Rho JM, Kurrasch DM. A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target. Brain : a Journal of Neurology. PMID 29373639 DOI: 10.1093/Brain/Awx364  0.363
2018 Simeone TA, Simeone KA, Stafstrom CE, Rho JM. Do ketone bodies mediate the anti-seizure effects of the ketogenic diet? Neuropharmacology. PMID 29325899 DOI: 10.1016/J.Neuropharm.2018.01.011  0.797
2017 Chun KC, Ma SC, Oh H, Rho JM, Kim DY. Ketogenic diet-induced extension of longevity in epileptic Kcna1-null mice is influenced by gender and age at treatment onset. Epilepsy Research. 140: 53-55. PMID 29245026 DOI: 10.1016/j.eplepsyres.2017.11.005  0.352
2017 French JA, Koepp M, Naegelin Y, Vigevano F, Auvin S, Rho JM, Rosenberg E, Devinsky O, Olofsson PS, Dichter MA. Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia. 58: 69-82. PMID 28675558 DOI: 10.1111/Epi.13779  0.318
2017 Cheng N, Alshammari F, Hughes E, Khanbabaei M, Rho JM. Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism. Plos One. 12: e0179409. PMID 28609458 DOI: 10.1371/journal.pone.0179409  0.318
2017 Simeone TA, Simeone KA, Rho JM. Ketone Bodies as Anti-Seizure Agents. Neurochemical Research. PMID 28397070 DOI: 10.1007/S11064-017-2253-5  0.801
2017 Cheng N, Rho JM, Masino SA. Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches. Frontiers in Molecular Neuroscience. 10: 34. PMID 28270747 DOI: 10.3389/fnmol.2017.00034  0.351
2017 Scantlebury MH, Chun KC, Ma SC, Rho JM, Kim DY. Adrenocorticotropic Hormone Protects Learning and Memory Function in Epileptic Kcna1-null mice. Neuroscience Letters. PMID 28249786 DOI: 10.1016/j.neulet.2017.02.069  0.362
2017 Leal-Campanario R, Alarcon-Martinez L, Rieiro H, Martinez-Conde S, Alarcon-Martinez T, Zhao X, LaMee J, Popp PJ, Calhoun ME, Arribas JI, Schlegel AA, Stasi LL, Rho JM, Inge L, Otero-Millan J, et al. Abnormal Capillary Vasodynamics Contribute to Ictal Neurodegeneration in Epilepsy. Scientific Reports. 7: 43276. PMID 28240297 DOI: 10.1038/Srep43276  0.391
2016 Mychasiuk R, Rho JM. Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf/J) mouse model of autism spectrum disorder. Autism Research : Official Journal of the International Society For Autism Research. PMID 27529337 DOI: 10.1002/Aur.1682  0.309
2016 Simeone KA, Matthews SA, Rho JM, Simeone TA. Ketogenic diet treatment increases longevity in Kcna1-null mice, a model of sudden unexpected death in epilepsy. Epilepsia. PMID 27346881 DOI: 10.1111/Epi.13444  0.784
2016 Jiang Y, Gavrilovici C, Chansard M, Liu RH, Kiroski I, Parsons K, Park SK, Teskey GC, Rho JM, Nguyen MD. Ndel1 and Reelin Maintain Postnatal CA1 Hippocampus Integrity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 6538-52. PMID 27307241 DOI: 10.1523/Jneurosci.2869-15.2016  0.318
2016 Smith J, Rho JM, Teskey GC. Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder. Behavioural Brain Research. PMID 26876011 DOI: 10.1016/j.bbr.2016.02.015  0.316
2016 Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harbor Perspectives in Medicine. PMID 26801895 DOI: 10.1101/cshperspect.a022780  0.632
2015 Rho JM. How does the ketogenic diet induce anti-seizure effects? Neuroscience Letters. PMID 26222258 DOI: 10.1016/j.neulet.2015.07.034  0.466
2015 Rho JM. Inhibition of Lactate Dehydrogenase to Treat Epilepsy. The New England Journal of Medicine. 373: 187-9. PMID 26154793 DOI: 10.1056/NEJMcibr1503558  0.46
2015 Kim do Y, Simeone KA, Simeone TA, Pandya JD, Wilke JC, Ahn Y, Geddes JW, Sullivan PG, Rho JM. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Annals of Neurology. 78: 77-87. PMID 25899847 DOI: 10.1002/Ana.24424  0.782
2015 Bello-Espinosa LE, Rajapakse T, Rho JM, Buchhalter J. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy. Pediatric Neurology. 52: 509-16. PMID 25882078 DOI: 10.1016/j.pediatrneurol.2014.11.011  0.398
2015 Kim do Y, Abdelwahab MG, Lee SH, O'Neill D, Thompson RJ, Duff HJ, Sullivan PG, Rho JM. Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. Plos One. 10: e0119316. PMID 25848768 DOI: 10.1371/Journal.Pone.0119316  0.324
2014 Hartman AL, Rho JM. The New Ketone Alphabet Soup: BHB, HCA, and HDAC. Epilepsy Currents / American Epilepsy Society. 14: 355-7. PMID 25678874 DOI: 10.5698/1535-7597-14.6.355  0.512
2014 Swann JW, Rho JM. How is homeostatic plasticity important in epilepsy? Advances in Experimental Medicine and Biology. 813: 123-31. PMID 25012372 DOI: 10.1007/978-94-017-8914-1_10  0.423
2014 Stotz SC, Scott LO, Drummond-Main C, Avchalumov Y, Girotto F, Davidsen J, Gómez-Gárcia MR, Rho JM, Pavlov EV, Colicos MA. Inorganic polyphosphate regulates neuronal excitability through modulation of voltage-gated channels. Molecular Brain. 7: 42. PMID 24886461 DOI: 10.1186/1756-6606-7-42  0.353
2014 Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. Journal of Lipid Research. 55: 2211-28. PMID 24847102 DOI: 10.1194/jlr.R048975  0.372
2013 Ruskin DN, Svedova J, Cote JL, Sandau U, Rho JM, Kawamura M, Boison D, Masino SA. Ketogenic diet improves core symptoms of autism in BTBR mice. Plos One. 8: e65021. PMID 23755170 DOI: 10.1371/journal.pone.0065021  0.374
2013 Girotto F, Scott L, Avchalumov Y, Harris J, Iannattone S, Drummond-Main C, Tobias R, Bello-Espinosa L, Rho JM, Davidsen J, Teskey GC, Colicos MA. High dose folic acid supplementation of rats alters synaptic transmission and seizure susceptibility in offspring. Scientific Reports. 3: 1465. PMID 23492951 DOI: 10.1038/Srep01465  0.378
2013 Simeone TA, Simeone KA, Samson KK, Kim do Y, Rho JM. Loss of the Kv1.1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices. Neurobiology of Disease. 54: 68-81. PMID 23466697 DOI: 10.1016/J.Nbd.2013.02.009  0.774
2013 Hartman AL, Rho JM. The Biochemical Basis of Dietary Therapies for Neurological Disorders Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 34-44. DOI: 10.1002/9781118702772.ch5  0.491
2013 Hartman AL, Rho JM. Beyond Epilepsy: Ketogenic Diet Use in Other Disease States Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 225-231. DOI: 10.1002/9781118702772.ch28  0.557
2012 Patel M, Rho JM. Sweets Are BAD for Seizures. Epilepsy Currents / American Epilepsy Society. 12: 218-9. PMID 23447715 DOI: 10.5698/1535-7511-12.6.218  0.393
2012 Kobow K, Auvin S, Jensen F, Löscher W, Mody I, Potschka H, Prince D, Sierra A, Simonato M, Pitkänen A, Nehlig A, Rho JM. Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia. 53: 1868-76. PMID 23061663 DOI: 10.1111/J.1528-1167.2012.03716.X  0.608
2012 Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. Plos One. 7: e36197. PMID 22563484 DOI: 10.1371/journal.pone.0036197  0.316
2012 Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Frontiers in Pharmacology. 3: 59. PMID 22509165 DOI: 10.3389/fphar.2012.00059  0.328
2012 Rho JM, Stafstrom CE. The ketogenic diet: what has science taught us? Epilepsy Research. 100: 210-7. PMID 21856126 DOI: 10.1016/j.eplepsyres.2011.05.021  0.332
2012 Abdelwahab MG, Woolf E, Fenton K, Stafford P, Preul MC, Rho JM, Lynch A, Scheck AC. Abstract 3217: Mechanistic analysis of the ketogenic diet versus KetoCal® as adjuvant treatments for malignant glioma Cancer Research. 72: 3217-3217. DOI: 10.1158/1538-7445.Am2012-3217  0.312
2011 Chapman KE, Kim DY, Rho JM, Ng YT, Kerrigan JF. Ketogenic diet in the treatment of seizures associated with hypothalamic hamartomas. Epilepsy Research. 94: 218-21. PMID 21377333 DOI: 10.1016/j.eplepsyres.2011.02.004  0.617
2011 Simeone KA, Sabesan S, Kim do Y, Kerrigan JF, Rho JM, Simeone TA. L-Type calcium channel blockade reduces network activity in human epileptic hypothalamic hamartoma tissue. Epilepsia. 52: 531-40. PMID 21269296 DOI: 10.1111/J.1528-1167.2010.02942.X  0.767
2010 Rho JM. How does altered metabolism lead to seizure control? Partially filling the knowledge gap. Epilepsy Currents / American Epilepsy Society. 10: 159-61. PMID 21157545 DOI: 10.1111/j.1535-7511.2010.01387.x  0.408
2010 Rho JM. Another Look at Early GABAergic Neurotransmission: Maybe It's Not So Exciting After All! Epilepsy Currents / American Epilepsy Society. 10: 128-30. PMID 20944825 DOI: 10.1111/j.1535-7511.2010.01378.x  0.38
2010 Stafford P, Abdelwahab MG, Kim do Y, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutrition & Metabolism. 7: 74. PMID 20831808 DOI: 10.1186/1743-7075-7-74  0.311
2010 Stein D, Chetty M, Rho JM. A "happy" toddler presenting with sudden, life-threatening seizures. Seminars in Pediatric Neurology. 17: 35-8. PMID 20434691 DOI: 10.1016/j.spen.2010.02.002  0.377
2010 Kim do Y, Vallejo J, Rho JM. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. Journal of Neurochemistry. 114: 130-41. PMID 20374433 DOI: 10.1111/j.1471-4159.2010.06728.x  0.308
2010 Masino SA, Rho JM. Mechanisms of ketogenic diet action Epilepsia. 51: 85. DOI: 10.1111/j.1528-1167.2010.02871.x  0.406
2009 Fenoglio-Simeone K, Mazarati A, Sefidvash-Hockley S, Shin D, Wilke J, Milligan H, Sankar R, Rho JM, Maganti R. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon. Epilepsy & Behavior : E&B. 16: 52-7. PMID 19682955 DOI: 10.1016/J.Yebeh.2009.07.022  0.414
2009 Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. Journal of Child Neurology. 24: 979-88. PMID 19535814 DOI: 10.1177/0883073809337162  0.36
2009 Fenoglio-Simeone KA, Wilke JC, Milligan HL, Allen CN, Rho JM, Maganti RK. Ketogenic diet treatment abolishes seizure periodicity and improves diurnal rhythmicity in epileptic Kcna1-null mice. Epilepsia. 50: 2027-34. PMID 19490051 DOI: 10.1111/j.1528-1167.2009.02163.x  0.4
2009 Rho JM. Arresting a seizure by dropping a little Acid. Epilepsy Currents / American Epilepsy Society. 9: 55-6. PMID 19421382 DOI: 10.1111/j.1535-7511.2008.01291.x  0.428
2009 Kossoff EH, Rho JM. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 406-14. PMID 19332337 DOI: 10.1016/j.nurt.2009.01.005  0.374
2009 Kim DY, Fenoglio KA, Kerrigan JF, Rho JM. Bicarbonate contributes to GABAA receptor-mediated neuronal excitation in surgically resected human hypothalamic hamartomas. Epilepsy Research. 83: 89-93. PMID 19022626 DOI: 10.1016/J.Eplepsyres.2008.09.008  0.58
2009 Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Research Reviews. 59: 293-315. PMID 18845187 DOI: 10.1016/J.Brainresrev.2008.09.002  0.671
2008 Rho JM, Sankar R. The ketogenic diet in a pill: is this possible? Epilepsia. 49: 127-33. PMID 19049610 DOI: 10.1111/J.1528-1167.2008.01857.X  0.33
2008 Glauser TA, Sankar R, Bainbridge J, Bebin M, Benbadis SR, Cantrell DTC, Faught RE, Gruenthal M, Hershkowitz LL, Holmes GL, Husain AM, Labiner DM, Montouris G, Naritoku DK, Olson BJ, ... ... Rho JM, et al. Core elements of epilepsy diagnosis and management: Expert consensus from the Leadership in Epilepsy, Advocacy, and Development (LEAD) faculty Current Medical Research and Opinion. 24: 3463-3477. PMID 19032128 DOI: 10.1185/03007990802561148  0.365
2008 Wu J, DeChon J, Xue F, Li G, Ellsworth K, Gao M, Liu Q, Yang K, Zheng C, He P, Tu J, Kim do Y, Rho JM, Rekate H, Kerrigan JF, et al. GABA(A) receptor-mediated excitation in dissociated neurons from human hypothalamic hamartomas. Experimental Neurology. 213: 397-404. PMID 18675803 DOI: 10.1016/J.Expneurol.2008.07.004  0.562
2008 Maalouf M, Rho JM. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. Journal of Neuroscience Research. 86: 3322-30. PMID 18646208 DOI: 10.1002/Jnr.21782  0.639
2008 Rho JM. Can reducing sugar retard kindling? Epilepsy Currents / American Epilepsy Society. 8: 83-4. PMID 18488064 DOI: 10.1111/j.1535-7511.2008.00247.x  0.423
2008 Kim do Y, Rho JM. The ketogenic diet and epilepsy. Current Opinion in Clinical Nutrition and Metabolic Care. 11: 113-20. PMID 18301085 DOI: 10.1097/MCO.0b013e3282f44c06  0.428
2008 Kim do Y, Fenoglio KA, Simeone TA, Coons SW, Wu J, Chang Y, Kerrigan JF, Rho JM. GABAA receptor-mediated activation of L-type calcium channels induces neuronal excitation in surgically resected human hypothalamic hamartomas. Epilepsia. 49: 861-71. PMID 18076645 DOI: 10.1111/J.1528-1167.2007.01455.X  0.775
2007 Rho JM. Substantia(ting) ketone body effects on neuronal excitability. Epilepsy Currents / American Epilepsy Society. 7: 142-4. PMID 17998978 DOI: 10.1111/j.1535-7511.2007.00206.x  0.434
2007 Sankar R, Rho JM. Do seizures affect the developing brain? Lessons from the laboratory. Journal of Child Neurology. 22: 21S-9S. PMID 17690084 DOI: 10.1177/0883073807303072  0.407
2007 Fenoglio KA, Wu J, Kim do Y, Simeone TA, Coons SW, Rekate H, Rho JM, Kerrigan JF. Hypothalamic hamartoma: basic mechanisms of intrinsic epileptogenesis. Seminars in Pediatric Neurology. 14: 51-9. PMID 17544947 DOI: 10.1016/J.Spen.2007.03.002  0.776
2007 Rho JM, Rogawski MA. The ketogenic diet: stoking the powerhouse of the cell. Epilepsy Currents / American Epilepsy Society. 7: 58-60. PMID 17505556 DOI: 10.1111/j.1535-7511.2007.00170.x  0.501
2007 Wu J, Chang Y, Li G, Xue F, DeChon J, Ellsworth K, Liu Q, Yang K, Bahadroani N, Zheng C, Zhang J, Rekate H, Rho JM, Kerrigan JF. Electrophysiological properties and subunit composition of GABAA receptors in patients with gelastic seizures and hypothalamic hamartoma. Journal of Neurophysiology. 98: 5-15. PMID 17428906 DOI: 10.1152/Jn.00165.2007  0.567
2007 Kim do Y, Davis LM, Sullivan PG, Maalouf M, Simeone TA, van Brederode J, Rho JM. Ketone bodies are protective against oxidative stress in neocortical neurons. Journal of Neurochemistry. 101: 1316-26. PMID 17403035 DOI: 10.1111/J.1471-4159.2007.04483.X  0.773
2007 Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 48: 43-58. PMID 17241207 DOI: 10.1111/j.1528-1167.2007.00915.x  0.439
2007 Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 145: 256-64. PMID 17240074 DOI: 10.1016/J.Neuroscience.2006.11.065  0.666
2006 Maalouf M, Takahashi CD, Reinkensmeyer DJ, Cooper DM, Rho JM. Impaired motor control in patients with benign focal epilepsy of childhood. Journal of Child Neurology. 21: 157-60. PMID 16566883 DOI: 10.1177/08830738060210020601  0.638
2005 Wu J, Xu L, Kim DY, Rho JM, St John PA, Lue LF, Coons S, Ellsworth K, Nowak L, Johnson E, Rekate H, Kerrigan JF. Electrophysiological properties of human hypothalamic hamartomas. Annals of Neurology. 58: 371-82. PMID 16130091 DOI: 10.1002/Ana.20580  0.596
2005 Simeone TA, Rho JM, Baram TZ. Single channel properties of hyperpolarization-activated cation currents in acutely dissociated rat hippocampal neurones. The Journal of Physiology. 568: 371-80. PMID 16123099 DOI: 10.1113/Jphysiol.2005.093161  0.751
2005 Kim HL, Aldridge J, Rho JM. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center. Journal of Child Neurology. 20: 212-9. PMID 15832611 DOI: 10.1177/08830738050200030801  0.407
2004 Noh HS, Lee HP, Kim DW, Kang SS, Cho GJ, Rho JM, Choi WS. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Research. Molecular Brain Research. 129: 80-7. PMID 15469884 DOI: 10.1016/j.molbrainres.2004.06.020  0.31
2004 Golumbek PT, Rho JM, Spain WJ, van Brederode JF. Effects of flunarizine on spontaneous synaptic currents in rat neocortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 176-82. PMID 15340775 DOI: 10.1007/s00210-004-0968-8  0.383
2004 Rho JM. Basic science behind the catastrophic epilepsies. Epilepsia. 45: 5-11. PMID 15283705 DOI: 10.1111/j.0013-9580.2004.05001.x  0.393
2004 Simeone TA, Sanchez RM, Rho JM. Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system. Journal of Child Neurology. 19: 343-60; discussion 3. PMID 15224708 DOI: 10.1177/088307380401900507  0.7
2004 Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Annals of Neurology. 55: 576-80. PMID 15048898 DOI: 10.1002/Ana.20062  0.308
2003 Donevan SD, White HS, Anderson GD, Rho JM. Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-beta-hydroxybutyrate. Epilepsia. 44: 1274-9. PMID 14510820 DOI: 10.1046/J.1528-1157.2003.07203.X  0.739
2003 Bingel U, Pinter JD, Sotero de Menezes M, Rho JM. Intravenous immunoglobulin as adjunctive therapy for juvenile spasms. Journal of Child Neurology. 18: 379-82. PMID 12886970 DOI: 10.1177/08830738030180061001  0.37
2003 Bough KJ, Schwartzkroin PA, Rho JM. Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia. 44: 752-60. PMID 12790887 DOI: 10.1046/J.1528-1157.2003.55502.X  0.61
2003 Simeone TA, Donevan SD, Rho JM. Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system. Journal of Child Neurology. 18: 39-48; discussion 49. PMID 12661937 DOI: 10.1177/08830738030180012101  0.78
2002 Storey TW, Rho JM, White SS, Sankar R, Szot P. Age-dependent differences in flurothyl-induced c-fos and c-jun mRNA expression in the mouse brain. Developmental Neuroscience. 24: 294-9. PMID 12457067 DOI: 10.1159/000066743  0.365
2002 de Menezes MA, Rho JM. Clinical and electrographic features of epileptic spasms persisting beyond the second year of life. Epilepsia. 43: 623-30. PMID 12060022 DOI: 10.1046/j.1528-1157.2002.28401.x  0.403
2002 Grant AC, Rho JM. Ictal EEG patterns in band heterotopia. Epilepsia. 43: 403-7. PMID 11952771 DOI: 10.1046/j.1528-1157.2002.42601.x  0.389
2002 Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia. 43: 358-61. PMID 11952765 DOI: 10.1046/J.1528-1157.2002.47901.X  0.739
2002 Schwartzkroin PA, Rho JM. Preface International Review of Neurobiology. 49: xvi-xviii.  0.389
2001 Szot P, Weinshenker D, Rho JM, Storey TW, Schwartzkroin PA. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Research. Developmental Brain Research. 129: 211-4. PMID 11506865 DOI: 10.1016/S0165-3806(01)00213-9  0.592
2001 Rho JM, Storey TW. Molecular ontogeny of major neurotransmitter receptor systems in the mammalian central nervous system: norepinephrine, dopamine, serotonin, acetylcholine, and glycine. Journal of Child Neurology. 16: 271-280; discussion . PMID 11332462 DOI: 10.1177/088307380101600407  0.329
1999 Rho JM, Kim DW, Robbins CA, Anderson GD, Schwartzkroin PA. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Research. 37: 233-40. PMID 10584973 DOI: 10.1016/S0920-1211(99)00068-6  0.548
1999 Rho JM, Szot P, Tempel BL, Schwartzkroin PA. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice. Developmental Neuroscience. 21: 320-7. PMID 10575255 DOI: 10.1159/000017381  0.587
1999 Schwartzkroin PA, Rho JM. Editorial Epilepsy Research. 37: 169. DOI: 10.1016/S0920-1211(99)00097-2  0.389
1998 Grauert M, Rho JM, Subramaniam S, Rogawski MA. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL. The Journal of Pharmacology and Experimental Therapeutics. 285: 767-76. PMID 9580625  0.504
1997 Rho JM, Donevan SD, Rogawski MA. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. The Journal of Pharmacology and Experimental Therapeutics. 280: 1383-91. PMID 9067327  0.723
1996 Rho JM, Donevan SD, Rogawski MA. Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. The Journal of Physiology. 497: 509-22. PMID 8961191 DOI: 10.1113/Jphysiol.1996.Sp021784  0.719
1996 Rho JM, Donevan SD, Rogawski MA. Direct activation of GABA(A) receptors by barbiturates in cultured rat hippocampal neurons Journal of Physiology. 497: 509-522.  0.721
1995 Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA. Felbamate block of the N-methyl-D-aspartate receptor. The Journal of Pharmacology and Experimental Therapeutics. 273: 878-86. PMID 7752093  0.715
1994 Rho JM, Donevan SD, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors. Annals of Neurology. 35: 229-34. PMID 8109904 DOI: 10.1002/ana.410350216  0.753
1994 Sofia RD, Rho JM, Donevan SD, Subramaniam S, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: Opposing effects on N-methyl-D-aspartate and γ-aminobutyric acid(A) receptors [1] Annals of Neurology. 36: 677-678. PMID 7944305  0.709
Show low-probability matches.